These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21950242)

  • 1. Diseases endemic in developing countries: how to incentivize innovation.
    Weilbaecher A
    Ann Health Law; 2009; 18(2):281-309, 7 p. preceding i. PubMed ID: 21950242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wild-card patent extensions as a means to incentivize research and development of antibiotics.
    Sonderholm J
    J Law Med Ethics; 2009; 37(2):240-6. PubMed ID: 19493069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ownership of knowledge--the role of patents in pharmaceutical R&D.
    Correa CM
    Bull World Health Organ; 2004 Oct; 82(10):784-7; discussion 787-90. PubMed ID: 15643801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of patents and research and development incentives in biopharmaceutical innovation.
    Grabowski HG; DiMasi JA; Long G
    Health Aff (Millwood); 2015 Feb; 34(2):302-10. PubMed ID: 25646111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary: innovation policy for a new era.
    Kapczynski A
    J Law Med Ethics; 2009; 37(2):264-8. PubMed ID: 19493071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Economic Theory of Patent Protection and Pandemic Influenza Vaccines: Do Patents Really Incentivize Innovation in the Field?
    Eccleston-Turner M
    Am J Law Med; 2016 May; 42(2-3):572-597. PubMed ID: 29086638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intellectual property. Balancing innovation and access: patent challenges tip the scales.
    Higgins MJ; Graham SJ
    Science; 2009 Oct; 326(5951):370-1. PubMed ID: 19833944
    [No Abstract]   [Full Text] [Related]  

  • 8. Revitalizing the patent system to incentivize pharmaceutical innovation: the potential of claims with means-plus-function clauses.
    Tang WL
    Duke Law J; 2013 Feb; 62(5):1069-108. PubMed ID: 25330553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of patent sharing in neglected disease drug discovery.
    Edlin C
    Future Med Chem; 2011 Sep; 3(11):1331-4. PubMed ID: 21879838
    [No Abstract]   [Full Text] [Related]  

  • 10. A new prize system for drug innovation.
    Gandjour A; Chernyak N
    Health Policy; 2011 Oct; 102(2-3):170-7. PubMed ID: 21724290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patent-sharing scheme for neglected diseases may have catch.
    Waters H
    Nat Med; 2011 Dec; 17(12):1529. PubMed ID: 22146436
    [No Abstract]   [Full Text] [Related]  

  • 12. Patents with an "I" = patients.
    Martin AO; Devadas SK
    Ann Health Law; 2009; 18(2):261-80, 7 p. preceding 7. PubMed ID: 21950241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How should we support pharmaceutical innovation?
    Grootendorst P
    Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent law--balancing profit maximization and public access to technology.
    Beckerman-Rodau A
    Columbia Sci Technol Law Rev; 2003; 4():E1. PubMed ID: 15977333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing 15 proposals for promoting innovation and access to medicines globally.
    Hoffman SJ; So K;
    Ann Glob Health; 2014; 80(6):432-43. PubMed ID: 25960092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can open-source drug R&D repower pharmaceutical innovation?
    Munos B
    Clin Pharmacol Ther; 2010 May; 87(5):534-6. PubMed ID: 20407458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taking TRIPS to India--Novartis, patent law, and access to medicines.
    Mueller JM
    N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473
    [No Abstract]   [Full Text] [Related]  

  • 18. New models for pharmaceutical innovation in low-income countries.
    Ardal C; Iversen JH; Myhr K
    Tidsskr Nor Laegeforen; 2011 Oct; 131(20):2016-8. PubMed ID: 22016131
    [No Abstract]   [Full Text] [Related]  

  • 19. Building local research and development capacity for the prevention and cure of neglected diseases: the case of India.
    Kettler HE; Modi R
    Bull World Health Organ; 2001; 79(8):742-7. PubMed ID: 11545331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Societal costs versus savings from wild-card patent extension legislation to spur critically needed antibiotic development.
    Spellberg B; Miller LG; Kuo MN; Bradley J; Scheld WM; Edwards JE
    Infection; 2007 Jun; 35(3):167-74. PubMed ID: 17565458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.